Kinnate Biopharma: Doubles in Nasdaq debut

Kinnate Biopharma

03/12/2020 17:53

** Shares of biopharmaceutical company  KNTE.O  jump more
than two-fold to $41.66 in their market debut
    ** Stock among the biggest percentage gainers in Nasdaq
    ** Co's shares opened at $40, compared with the IPO price of
$20 per share  urn:newsml:reuters.com:*:nRSD20p5qM
    ** Goldman Sachs, SVB Leerink, Piper Sandler, Wedbush
Pacgrow are the underwriters of the IPO 
    ** The gross proceeds from the offering were expected to be
$240 mln  urn:newsml:reuters.com:*:nGNXVMykC 

 (Reporting by Rithika Krishna)
 ((Rithika.Krishna@thomsonreuters.com;))